TargetMol

Clofazimine

Product Code:
 
TAR-T0377
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T0377-500mg500mg£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0377-1mL1 mL * 10 mM (in DMSO)£115.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Clofazimine is a phenazine dye with anti-mycobacterial and anti-inflammatory activities. Clofazimine has a slow bactericidal effect on Mycobacterium leprae and is active against various other Mycobacteria.
CAS:
2030-63-9
Formula:
C27H22Cl2N4
Molecular Weight:
473.4
Pathway:
DNA Damage/DNA Repair; Microbiology/Virology
Purity:
0.9927
SMILES:
CC(C)N=c1cc2n(-c3ccc(Cl)cc3)c3ccccc3nc2cc1Nc1ccc(Cl)cc1
Target:
DNA; Antibacterial; Antibiotic

References

1. Arbiser JL, et al. J Am Acad Dermatol, 1995, 32(2 Pt 1), 241-247. 2. Van Rensburg CE, et al. Antimicrob Agents Chemother, 1992, 36(12), 2729-2735. 3. Reddy VM, et al. Antimicrob Agents Chemother, 1996, 40(3), 633-636. 4. Adams LB, et al. Antimicrob Agents Chemother, 1999, 43(7), 1638-1643. 5. Peters K, et al. J Antimicrob Chemother, 2000, 45(1), 77-83. 6. Bowden G D, Land K M, O'Connor R M, et al. High-throughput screen of drug repurposing library identifies inhibitors of Sarcocystis neurona growth[J]. International Journal for Parasitology: Drugs and Drug Resistance. 2018 Apr?8(1): 137-144.